Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Köppel

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Stem Cells (Dayton, Ohio)|April 9, 2009
Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase RChristiane A Opitz, Ulrike M Litzenburger, Christian Lutz, et al.
Regulatory Peptides|September 20, 2014
Carnosine treatment in combination with ACE inhibition in diabetic ratsV Peters, E Riedl, M Braunagel, et al.
Plos One|July 30, 2021
Description and analysis of representative COVID-19 cases-A retrospective cohort studyYannis Herrmann, Tim Starck, Niall Brindl, et al.
Journal of Diabetes Research|May 30, 2017
The <i>CNDP1</i> (CTG)<sub>5</sub> Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes DurationThomas Albrecht, Shiqi Zhang, Jana D Braun, et al.
Wiener Medizinische Wochenschrift (1946)|November 23, 2013
[Dementia in Germany: results of an interdisciplinary expert workshop]Susanne Blödt, Adelheid Kuhlmey, Sabine Bartholomeyczik, et al.
Scientific Reports|March 11, 2017
Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob MiceThomas Albrecht, Maaike Schilperoort, Shiqi Zhang, et al.
Haematologica|January 8, 2026
Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myelomaSeungbin Han, Umair Munawar, Marietta Truger, et al.
Clinical Epigenetics|April 2, 2026
Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myelomaSeungbin Han, Larissa Haertle, Umair Munawar, et al.
Diabetes|July 28, 2005
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1Bart Janssen, Daniela Hohenadel, Paul Brinkkoetter, et al.
Leukemia|March 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapyUmair Munawar, Johanna Thurner, Silvia Nerreter, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Stem Cells (Dayton, Ohio)|April 9, 2009
Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase RChristiane A Opitz, Ulrike M Litzenburger, Christian Lutz, et al.
Regulatory Peptides|September 20, 2014
Carnosine treatment in combination with ACE inhibition in diabetic ratsV Peters, E Riedl, M Braunagel, et al.
Plos One|July 30, 2021
Description and analysis of representative COVID-19 cases-A retrospective cohort studyYannis Herrmann, Tim Starck, Niall Brindl, et al.
Journal of Diabetes Research|May 30, 2017
The <i>CNDP1</i> (CTG)<sub>5</sub> Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes DurationThomas Albrecht, Shiqi Zhang, Jana D Braun, et al.
Wiener Medizinische Wochenschrift (1946)|November 23, 2013
[Dementia in Germany: results of an interdisciplinary expert workshop]Susanne Blödt, Adelheid Kuhlmey, Sabine Bartholomeyczik, et al.
Scientific Reports|March 11, 2017
Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob MiceThomas Albrecht, Maaike Schilperoort, Shiqi Zhang, et al.
Haematologica|January 8, 2026
Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myelomaSeungbin Han, Umair Munawar, Marietta Truger, et al.
Clinical Epigenetics|April 2, 2026
Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myelomaSeungbin Han, Larissa Haertle, Umair Munawar, et al.
Diabetes|July 28, 2005
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1Bart Janssen, Daniela Hohenadel, Paul Brinkkoetter, et al.
Leukemia|March 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapyUmair Munawar, Johanna Thurner, Silvia Nerreter, et al.
Pageof 26